Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF641 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927057 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRG1-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IGHG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R2P9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM205A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on